Respiratory care in myotubular myopathy

Area of Science:

• Neuromuscular Disorders
• Genetics
• Respiratory Medicine

Background:

• X-linked myotubular myopathy (XMTM) is a severe congenital neuromuscular disorder.
• Pathogenic variants in the MTM1 gene cause XMTM, affecting myotubularin function.
• Respiratory failure is a primary cause of morbidity and mortality in XMTM.

Purpose of the Study:

• To review common respiratory issues in XMTM.
• To discuss current supportive respiratory management strategies.
• To summarize recent translational research and novel therapeutic advancements.

Main Methods:

• Case review of four illustrative patients with XMTM.
• Literature review of current respiratory management.
• Summary of ongoing translational research in XMTM therapeutics.

Main Results:

• XMTM patients often require intensive respiratory support.
• Current management focuses on secretion clearance, ventilation, and infection prevention.
• Emerging therapies including gene therapy show promise for XMTM.

Conclusions:

• Respiratory management in XMTM is critical and evolving.
• Novel therapeutic strategies offer significant hope for improved outcomes.
• Continued research is vital for advancing XMTM patient care.